Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial

Yu Seob Shin,1,* Li Tao Zhang,1,* Jae Hyung You,1 In Sung Choi,1 Chen Zhao,2 Jong Kwan Park1 1Department of Urology, Chonbuk National University and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Medical Device Clinical Trial Center of Chonb...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shin YS, Zhang LT, You JH, Choi IS, Zhao C, Park JK
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
benign prostate hyperplasia
tamsulosin
solifenacin
combination
transurethral resection of the prostate (TURP)
Geriatrics
RC952-954.6
Acceso en línea:https://doaj.org/article/12acded74845476d9d408c3e4f35a614
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/12acded74845476d9d408c3e4f35a614

Ejemplares similares